Overview
News
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Team
11-50
employees, estimated range
Backers
1
APEX Ventures
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
Fiber ElementsSeed $2.8M · 14 mo ago
Fiber Elements offers technology for the fully automated production of basalt fiber reinforcement structures.
Wise TechVenture round $25k · 12 mo ago • Founded 2024
Wise Tech — Software development consulting and AI application initiatives for forward-thinking businesses.
Lattice51-200 employees • 10 roles
Join 5,000+ forward-thinking teams using Lattice’s HR and AI tools to manage people and performance — all on one trusted platform.
page11-50 employees
Enabling Better Health via the Gut Microbiome. NutriLeads develops and supplies award-winning, plant-based, precision prebiotic fibers that…
Discover the story that drives Walnut's codeless product demo platform. Get to know the team who provides you with the ability to create…
MichromaVenture round $270k · 10 mo ago • Founded 2019 • 11-50 employees
Michroma produces natural food colourants using fungal fermentation. Its biotechnology replaces synthetic dyes in food manufacturing. The…

Overview

Forward thinking to reverse cell ageing. SENISCA targets the process of cellular ageing (senescence) via the development of RNA senotherapeutics which specifically target the causative molecular mechanisms that drive senescence.

News

Press release PRNewswire 2 years ago
LifeSpan Vision Ventures Invests in SENISCA
/PRNewswire/ -- LifeSpan Vision Ventures, an investment firm specializing in longevity biotech investments, today announced an investment in SENISCA, an RNA...
Read more
Report
News YahooFinance 2 years ago
SENISCA secures additional £3.7 million financing to support rapid development of senotherapeutic platform to treat age-related disease
SENISCA secures additional £3.7 million financing to support rapid development of senotherapeutic platform to treat age-related disease £3.7 million seed financing supported by consortium of new and existing investors will fund continued preclinical devel
Read more
Report
News FinanzNachrichten.de 3 years ago
Senisca Ltd: SENISCA appoints Dr. Sarah Cole as Chief Executive Officer
SENISCA appoints Dr. Sarah Cole as Chief Executive Officer Exeter, UK - 02 November 2023: SENISCA SENISCA, a biotechnology company developing RNA based therapeutics to reverse cellular senescence and
Read more
Report
Pro access
Upgrade to see all 19 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.